| 1 |
hepatitis C virus
(39693 times)
|
Gastroenterology
(8796 times)
|
HBV (3993 times)
HCC (2885 times)
SVR (2767 times)
|
1989 [Post-transfusion non-A, non-B hepatitis: is a specific test in sight?].
|
| 2 |
hepatitis C virus infection
(220 times)
|
Gastroenterology
(50 times)
|
HCC (20 times)
IFN (17 times)
SVR (17 times)
|
1993 [How many patients with chronic viral hepatitis qualify for interferon therapy? Prospective analysis of university ambulatory care].
|
| 3 |
HCVcc
(125 times)
|
Virology
(47 times)
|
HCVpp (30 times)
SR-BI (10 times)
siRNA (7 times)
|
2006 Hepatitis C virus entry: potential receptors and their biological functions.
|
| 4 |
hog cholera virus
(96 times)
|
Veterinary Medicine
(44 times)
|
BVDV (29 times)
BDV (9 times)
mAbs (9 times)
|
1968 The purification and concentration of hog cholera virus.
|
| 5 |
hippocampal volume
(34 times)
|
Neurology
(16 times)
|
MRI (9 times)
AD (6 times)
MCI (6 times)
|
1997 11C-flumazenil PET, volumetric MRI, and quantitative pathology in mesial temporal lobe epilepsy.
|
| 6 |
human coronavirus
(32 times)
|
Virology
(17 times)
|
BCV (5 times)
HEV (4 times)
HI (3 times)
|
1981 Two antigenic groups of human coronaviruses detected by using enzyme-linked immunosorbent assay.
|
| 7 |
HCV-Ab
(7 times)
|
Gastroenterology
(2 times)
|
HBsAg (2 times)
HIV (2 times)
ART (1 time)
|
1996 [Familial transmission of hepatitis C virus].
|
| 8 |
human calicivirus
(6 times)
|
Microbiology
(3 times)
|
ELISA (1 time)
ELISAs (1 time)
IEM (1 time)
|
1985 Humoral immunity in infants with gastroenteritis caused by human calicivirus.
|
| 9 |
hepatitis C virus antibody
(5 times)
|
Medicine
(2 times)
|
CHD (1 time)
CV (1 time)
CVD (1 time)
|
1990 [Hepatitis C virus antibodies (HCV) in patients treated with chronic hemodialysis].
|
| 10 |
high conservation value
(4 times)
|
Environmental Health
(2 times)
|
HCS (1 time)
IPA (1 time)
IUCN (1 time)
|
2015 Taking high conservation value from forests to freshwaters.
|
| 11 |
HC virus
(3 times)
|
Veterinary Medicine
(2 times)
|
HC (2 times)
BVDV (1 time)
HCC (1 time)
|
1976 Natural infection of pigs with bovine viral diarrhea virus and its differential diagnosis from hog cholera.
|
| 12 |
HCV infection
(3 times)
|
Biomedical Research
(1 time)
|
alpha-IFN (1 time)
SHF (1 time)
TBARS (1 time)
|
2001 [Cryoglobulinemia and hepatitis C virus infection].
|
| 13 |
hepacivirus
(3 times)
|
Chemistry
(1 time)
|
dsRNA (1 time)
|
2007 Status Presens of Antiviral Drugs And Strategies: Part I: DNA Viruses and Retroviruses.
|
| 14 |
hepatitis C virus genome
(3 times)
|
Cell Biology
(1 time)
|
RFLP (1 time)
|
1996 Improved amplification system for detection of hepatitis C virus genome that simultaneously differentiates viral genotypes.
|
| 15 |
hepatitis virus type C
(3 times)
|
Medicine
(1 time)
|
CH (1 time)
DM (1 time)
HBs (1 time)
|
1994 A seroepidemiological study of hepatitis C virus (HCV) in an area with a high prevalence of chronic liver disease in the Kyushu district of Japan.
|
| 16 |
HIV-hepatitis C
(3 times)
|
Patient Compliance
(1 time)
|
DAA (1 time)
HIV (1 time)
IL-10 (1 time)
|
2010 Gender differences in clinical, immunological, and virological outcomes in highly active antiretroviral-treated HIV-HCV coinfected patients.
|
| 17 |
HCV group
(2 times)
|
Gastroenterology
(1 time)
|
HBV (2 times)
HCC (2 times)
AFP (1 time)
|
2007 Significance of hepatitis B virus surface antigen, hepatitis C virus expression in hepatocellular carcinoma and pericarcinomatous tissues.
|
| 18 |
HCV-positive group
(2 times)
|
Tooth Diseases
(1 time)
|
OLP (2 times)
ICC (1 time)
|
2006 Clinicopathologic characteristics of hepatitis C virus-associated intrahepatic cholangiocarcinoma.
|
| 19 |
HCVser
(2 times)
|
Clinical Laboratory Techniques
(1 time)
|
HLCs (1 time)
iPSCs (1 time)
MSCs (1 time)
|
2011 Intracellular delivery of serum-derived hepatitis C virus.
|
| 20 |
hepatitis C virus chronic infection
(2 times)
|
Allergy and Immunology
(2 times)
|
AT (1 time)
HCVrA (1 time)
IMO (1 time)
|
2008 High values of CXCL10 serum levels in patients with hepatitis C associated mixed cryoglobulinemia in presence or absence of autoimmune thyroiditis.
|
| 21 |
hepatitis C virus core protein
(2 times)
|
Botany
(1 time)
|
FBN (1 time)
GQD-SH (1 time)
PG (1 time)
|
2012 Dual targeting of a mature plastoglobulin/fibrillin fusion protein to chloroplast plastoglobules and thylakoids in transplastomic tobacco plants.
|
| 22 |
hepatitis C virus-positive
(2 times)
|
Epidemiology
(1 time)
|
CLD (1 time)
HR (1 time)
PEG-IFN (1 time)
|
1998 Systematic cutaneous examination in hepatitis C virus infected patients.
|
| 23 |
hepatitis type-C virus
(2 times)
|
Genetics
(1 time)
|
CI (1 time)
HRM (1 time)
OR (1 time)
|
2015 Identification of mutations in the HVR1 and PKR-BD regions in HCV-infected patients resistant to PEG-IFNalpha/RBV therapy.
|
| 24 |
high-cholesterol plus vitamins C+E
(2 times)
|
Vascular Diseases
(2 times)
|
HC (2 times)
NC (2 times)
LDL (1 time)
|
2001 Vitamins C and E attenuate plasminogen activator inhibitor-1 (PAI-1) expression in a hypercholesterolemic porcine model of angioplasty.
|
| 25 |
human chromosome vector
(2 times)
|
Genetics
(2 times)
|
---
|
2001 Efficient male and female germline transmission of a human chromosomal vector in mice.
|
| 26 |
hybrid cooling vest
(2 times)
|
|
PAS (1 time)
PCMs (1 time)
PeSA (1 time)
|
2016 Hybrid cooling vest for cooling between exercise bouts in the heat: Effects and practical considerations.
|
| 27 |
anti-HCV
(1 time)
|
Gastroenterology
(1 time)
|
AIH (1 time)
AMA (1 time)
ANA (1 time)
|
1997 A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
|
| 28 |
Anti-hepatitis C virus positivity
(1 time)
|
Medicine
(1 time)
|
---
|
1995 Anti-hepatitis C virus positivity (HCV) in Belgian volunteer blood donors: source of contamination and HCV-testing among donors and related recipients.
|
| 29 |
betweenhepatitis C virus
(1 time)
|
|
CT (1 time)
DNA (1 time)
HBV (1 time)
|
2020 A Rare Case of Hepatic Sarcoidosis Caused By Hepatitis B Virus and Treatment-Induced Opportunistic Infection.
|
| 30 |
challenge-hepatitis C virus
(1 time)
|
Health Services Research
(1 time)
|
VA (1 time)
|
2019 The health equity implementation framework: proposal and preliminary study of hepatitis C virus treatment.
|
| 31 |
chronic C virus
(1 time)
|
Medicine
(1 time)
|
GGT (1 time)
IFN (1 time)
|
2000 [Therapy of chronic hepatitis C with alpha-interferon in 182 patients. Evaluation of results, response predictive factors and side effects].
|
| 32 |
Flaviviridae-hepatitis C virus
(1 time)
|
Epidemiology
(1 time)
|
HIV (1 time)
IVDU (1 time)
|
2002 HCV and GBV-c/HGV infection in HIV positive patients in southern Italy.
|
| 33 |
had comorbid viral hepatitis C
(1 time)
|
Neurology
(1 time)
|
---
|
2022 [The structure of stroke and the effect of somatic and addiction diseases on its appearance and course in patients with HIV infection].
|
| 34 |
had pretransplant samples available for antihepatitis C virus
(1 time)
|
Transplantation
(1 time)
|
VOD (1 time)
|
1991 Hepatic veno-occlusive disease post-bone marrow transplantation in children conditioned with busulfan and cyclophosphamide: incidence, risk factors, and clinical outcome.
|
| 35 |
had raised transaminases and positive antihepatitis C virus
(1 time)
|
Pediatrics
(1 time)
|
---
|
1996 Lymphoblastoid interferon alfa treatment in chronic hepatitis C.
|
| 36 |
half-dose sofosbuvir in patients with acute infection withhepatitis C virus
(1 time)
|
Nephrology
(1 time)
|
eGFR (1 time)
|
2020 Acute hepatitis C treatment in advanced renal failure using 8 weeks of pan-genotypic daclatasvir and reduced-dose sofosbuvir.
|
| 37 |
has made antihepatitis C virus
(1 time)
|
Gastroenterology
(1 time)
|
DAAs (1 time)
NS (1 time)
RAVs (1 time)
|
2019 Effects of resistance-associated variants in genotype 2hepatitis C virus on viral replication and susceptibility to antihepatitis C virus drugs.
|
| 38 |
have revolutionised treatment for thehepatitis C virus
(1 time)
|
Health Services
(1 time)
|
DAAs (1 time)
|
2018 Uptake of and Expenditure on Direct-Acting Antiviral Agents for Hepatitis C Treatment in Australia.
|
| 39 |
have suggested that ribavirin may potentiate the antihepatitis C virus
(1 time)
|
Allergy and Immunology
(1 time)
|
IFN-alpha (1 time)
IL (1 time)
|
2001 Treatment with ribavirin and interferon-alpha reduces interferon-gamma expression in patients with chronic hepatitis C.
|
| 40 |
HBsAg, antihepatitis C virus
(1 time)
|
Microbiology
(1 time)
|
ANA (1 time)
ASO (1 time)
BP (1 time)
|
2020 Pediatric lupus nephritis - An evil cousin of its adult counterpart: A single-center based experience from a tertiary care hospital of Eastern India.
|
| 41 |
HCC in patients with chronic virus C
(1 time)
|
Natural Science Disciplines
(1 time)
|
CHC (1 time)
HCC (1 time)
LC (1 time)
|
2022 Serum Folate deficiency in HCV related Hepatocellular Carcinoma.
|
| 42 |
HCV and ALD for F1-2, F3 and F4
(1 time)
|
Gastroenterology
(1 time)
|
ALD (1 time)
LS (1 time)
|
2015 Inflammation-adapted liver stiffness values for improved fibrosis staging in patients with hepatitis C virus and alcoholic liver disease.
|
| 43 |
HCV and cirrhosis remained significant contributors to greater spending
(1 time)
|
Gastroenterology
(1 time)
|
---
|
2019 Prevalence, mortality and healthcare utilization among Medicare beneficiaries with Hepatitis C in Haemodialysis units.
|
| 44 |
HCV cohort
(1 time)
|
Virology
(1 time)
|
aHR (1 time)
AMD (1 time)
CIs (1 time)
|
2021 Increased Risk of Age-Related Macular Degeneration with Chronic Hepatitis C Virus Infection: A Nationwide Population-Based Propensity Score-Matched Cohort Study in Taiwan.
|
| 45 |
HCV coinfected patients tend to develop hepatitis C
(1 time)
|
Allergy and Immunology
(1 time)
|
---
|
2011 CXCR3 Expression Elevated on Peripheral CD8(+) Lymphocytes from HIV/HCV Coinfected Individuals.
|
| 46 |
HCV infections in 2015 in Japan was 1,905,187-2,490,873
(1 time)
|
|
NDB (1 time)
|
2022 Burden of chronic hepatitis B and C infections in 2015 and future trends in Japan: A simulation study.
|
| 47 |
HCV mono-infected
(1 time)
|
Allergy and Immunology
(1 time)
|
GrzB (1 time)
|
2015 Schistosome infection aggravates HCV-related liver disease and induces changes in the regulatory T-cell phenotype.
|
| 48 |
HCV provider
(1 time)
|
Gastrointestinal Diseases
(1 time)
|
CI (1 time)
DAAs (1 time)
FQHC (1 time)
|
2023 Barriers to Hepatitis C Virus Care and How Federally Qualified Health Centers Can Improve Patient Access to Treatment.
|
| 49 |
HCV pseudotypes VSVdeltaG
(1 time)
|
Allergy and Immunology
(1 time)
|
VSV (1 time)
|
2005 Efficient formation of vesicular stomatitis virus pseudotypes bearing the native forms of hepatitis C virus envelope proteins detected after sonication.
|
| 50 |
HCV related cirrhosis
(1 time)
|
Neurology
(1 time)
|
HCC (1 time)
JCV (1 time)
PML (1 time)
|
2016 Progressive Multifocal Leukoencephalopathy in a HIV Negative, Immunocompetent Patient.
|
| 51 |
HCV RNA positive
(1 time)
|
Biological Science Disciplines
(1 time)
|
HIV (1 time)
PWID (1 time)
|
2021 Role of direct and indirect social and spatial ties in the diffusion of HIV and HCV among people who inject drugs: a cross-sectional community-based network analysis in New Delhi, India.
|
| 52 |
HCV RNA undetectable
(1 time)
|
Neoplasms
(1 time)
|
AEs (1 time)
HBV (1 time)
HCC (1 time)
|
2022 Low-dose nivolumab in advanced hepatocellular carcinoma.
|
| 53 |
HCV RNA-negative
(1 time)
|
Communicable Diseases
(1 time)
|
aIRR (1 time)
CI (1 time)
CVD (1 time)
|
2019 Clinical Outcomes in Persons Coinfected With Human Immunodeficiency Virus and Hepatitis C Virus: Impact of Hepatitis C Virus Treatment.
|
| 54 |
HCV without signs/symptoms of lymphoproliferations/autoimmunity
(1 time)
|
Hematology
(1 time)
|
BAFF-R (1 time)
CV (1 time)
HCV-CV (1 time)
|
2022 B-cell activating factor (BAFF), BAFF promoter and BAFF receptor allelic variants in hepatitis C virus related Cryoglobulinemic Vasculitis and Non-Hodgkin's Lymphoma.
|
| 55 |
HCV-Hun
(1 time)
|
Complementary Therapies
(1 time)
|
---
|
1993 [Molecular cloning and sequencing of hepatitis C virus gene from human blood].
|
| 56 |
HCV-O strain
(1 time)
|
Biochemistry
(1 time)
|
IFN (1 time)
sO (1 time)
|
2005 Efficient replication of a full-length hepatitis C virus genome, strain O, in cell culture, and development of a luciferase reporter system.
|
| 57 |
HCV-related
(1 time)
|
Substance-Related Disorders
(1 time)
|
CALD (1 time)
HBV (1 time)
|
2002 Hepatocyte proliferation and apoptosis in relation to oxidative damage in alcohol-related liver disease.
|
| 58 |
HCV-titer
(1 time)
|
Substance-Related Disorders
(1 time)
|
ALD (1 time)
|
1993 Effects of alcohol on the replication of hepatitis C virus.
|
| 59 |
HCV-transmission, evidence is provided that TO.FE
(1 time)
|
Virology
(1 time)
|
---
|
2007 Molecular and cellular determinants of cell-to-cell transmission of HCV in vitro.
|
| 60 |
HCV-treated cohort
(1 time)
|
Virology
(1 time)
|
CI (1 time)
HR (1 time)
IFN (1 time)
|
2021 Analysis of Different Types of Interferon-Associated Retinopathy in Patients with Chronic Hepatitis C Virus Infection Treated with Pegylated Interferon Plus Ribavirin.
|
| 61 |
HCV/ALD
(1 time)
|
Gastrointestinal Diseases
(1 time)
|
ALD (1 time)
LT (1 time)
NASH (1 time)
|
2020 Nonalcoholic Steatohepatitis Becomes the Leading Indication for Liver Transplant Registrants Among US Adults Born Between 1945 and 1965.
|
| 62 |
HCVcAg
(1 time)
|
Clinical Laboratory Techniques
(1 time)
|
EIA (1 time)
|
2001 Performance of a conventional enzyme immunoassay for hepatitis C virus core antigen in the early phases of hepatitis C infection.
|
| 63 |
HCVcc-Luc
(1 time)
|
Drug Therapy
(1 time)
|
DAAs (1 time)
|
2016 Evaluation of antiviral drug synergy in an infectious HCV system.
|
| 64 |
HCVcoreAg protein
(1 time)
|
|
AFM (1 time)
|
2019 Detection of Hepatitis C Virus Core Protein in Serum Using Aptamer-Functionalized AFM Chips.
|
| 65 |
healthcare visit
(1 time)
|
Medicine
(1 time)
|
CMC (1 time)
IR (1 time)
IRR (1 time)
|
2020 Healthcare trajectory of children with rare bone disease attending pediatric emergency departments.
|
| 66 |
heel velocity
(1 time)
|
Nervous System Diseases
(1 time)
|
RCOF (1 time)
|
2013 Asymmetrical slip propensity: required coefficient of friction.
|
| 67 |
Hematocrit level
(1 time)
|
Clinical Medicine
(1 time)
|
NBT (1 time)
PV (1 time)
|
2015 The response of New-season Nile tilapia to Aeromonas hydrophila vaccine.
|
| 68 |
hepacivirus C virus
(1 time)
|
Virology
(1 time)
|
BovHepV (1 time)
|
2019 Presence of a Novel Subtype of Bovine Hepacivirus in China and Expanded Classification of Bovine Hepacivirus Strains Worldwide into 7 Subtypes.
|
| 69 |
heparin correlation value
(1 time)
|
Hospitals
(1 time)
|
APTT (1 time)
|
2011 Substitution of a heparin correlation value for activated partial thromboplastin time in heparin nomograms.
|
| 70 |
hepatic failure related to C virus
(1 time)
|
Microbiology
(1 time)
|
CT (1 time)
|
1998 Efficacy of a short-term amphotericin B + flucytosine combination therapy followed by itraconazole monotherapy in acute and chronic AIDS-associated cryptococcosis.
|
| 71 |
hepatitis A virus, C virus
(1 time)
|
Gastroenterology
(1 time)
|
ALT (1 time)
anti-HCV (1 time)
HBsAg (1 time)
|
1998 Sero-clearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis.
|
| 72 |
hepatitis and discovery of the pathogen
(1 time)
|
|
---
|
2020 Hepatitis C: milestones from discovery to clinicalcure.
|
| 73 |
hepatitis B and/or C viruses
(1 time)
|
Acquired Immunodeficiency Syndrome
(1 time)
|
CLD (1 time)
|
2006 Severe liver disease associated with prolonged exposure to antiretroviral drugs.
|
| 74 |
Hepatitis C is a blood-borne virus
(1 time)
|
Medicine
(1 time)
|
EudraCT (1 time)
IEPS (1 time)
PWID (1 time)
|
2019 Randomised controlled trial conducted in injecting equipment provision sites to compare the effectiveness of different hepatitis C treatment regimens in people who inject drugs: A Direct obserVed therApy versus fortNightly CollEction study for HCV treatment-ADVANCE HCV protocol study.
|
| 75 |
hepatitis C virus associated cirrhosis
(1 time)
|
Gastroenterology
(1 time)
|
ALc (1 time)
ALcW (1 time)
CC (1 time)
|
2011 Lack of association of primary iron overload and common HFE gene mutations with liver cirrhosis in adult Indian population.
|
| 76 |
Hepatitis C virus cases
(1 time)
|
Parasitology
(1 time)
|
CMIR (1 time)
|
1999 Cell mediated immune response in chronic liver diseases: schistosomal, viral and neoplastic.
|
| 77 |
hepatitis C virus cirrhosis
(1 time)
|
Transplantation
(1 time)
|
HCV-Ab (1 time)
UNOS (1 time)
|
2006 No improvement in long-term liver transplant graft survival in the last decade: an analysis of the UNOS data.
|
| 78 |
hepatitis C virus related chronic hepatitis
(1 time)
|
Pathology
(1 time)
|
CL (1 time)
|
2006 Liver infiltrating mononuclear cells in children with type 1 autoimmune hepatitis.
|
| 79 |
Hepatitis C Virus seropositive
(1 time)
|
Brain
(1 time)
|
MDE (1 time)
|
2003 [Benefits of a preventive psychiatric accompaniment in patients Hepatitis C Virus seropositive (HCV): prospective study concerning 39 patients].
|
| 80 |
hepatitis C virus-related
(1 time)
|
Neoplasms
(1 time)
|
HCC (1 time)
|
2019 Prognostic profile of patients with non-viral hepatocellular carcinoma: A comparative study with hepatitis C virus-related hepatocellular carcinoma using data mining analysis.
|
| 81 |
hepatitis C virus
(1 time)
|
Chemistry, Pharmaceutical
(1 time)
|
HIV (1 time)
TAM (1 time)
VSV (1 time)
|
2019 Tamoxifen Protects from Vesicular Stomatitis Virus Infection.
|
| 82 |
hepatitis C-positive
(1 time)
|
Acquired Immunodeficiency Syndrome
(1 time)
|
CSAT (1 time)
|
2007 A model of integrated primary care for HIV-positive patients with underlying substance use and mental illness.
|
| 83 |
hepatitis C-viremic donors to hepatitis C
(1 time)
|
Cardiac Surgical Procedures
(1 time)
|
DAA (1 time)
|
2020 The impact of hepatitis C viremic donor lung allograft characteristics on post-transplantation outcomes.
|
| 84 |
hepatitis, is caused by a single-stranded RNA virus
(1 time)
|
Dentistry
(1 time)
|
---
|
1996 Hepatitis C virus infection.
|
| 85 |
hepatocellular virus
(1 time)
|
Molecular Biology
(1 time)
|
DAB (1 time)
HCC (1 time)
|
2018 Purinoceptor expression in hepatocellular virus (HCV)-induced and non-HCV hepatocellular carcinoma: an insight into the proviral role of the P2X4 receptor.
|
| 86 |
Hepatocellular volume
(1 time)
|
Medicine
(1 time)
|
EVA (1 time)
IHS (1 time)
SBA (1 time)
|
1988 Determinants of hepatic function in liver cirrhosis in the rat. Multivariate analysis.
|
| 87 |
hepatotropic viruses, especially hepatitis virus C
(1 time)
|
Substance-Related Disorders
(1 time)
|
HCC (1 time)
|
2003 National survey of hepatocellular carcinoma in heavy drinkers in Japan.
|
| 88 |
hepatotropic viruses, hepatitis B and hepatitis C
(1 time)
|
Neoplasms
(1 time)
|
HCC (1 time)
|
2006 Can therapy of hepatitis C affect the development of hepatocellular carcinoma?
|
| 89 |
high calorific value
(1 time)
|
Environmental Health
(1 time)
|
BMP (1 time)
FVW (1 time)
|
2017 Influence of chemical composition on biochemical methane potential of fruit and vegetable waste.
|
| 90 |
high case volume units
(1 time)
|
Gastrointestinal Diseases
(1 time)
|
LCV (1 time)
PUB (1 time)
|
2012 Management of peptic ulcer bleeding in different case volume workplaces: results of a nationwide inquiry in hungary.
|
| 91 |
High Contrast Visor
(1 time)
|
Aerospace Medicine
(1 time)
|
LEP (1 time)
SWAFs (1 time)
|
2000 Aircrew visors and color vision performance: a comparative and preliminary pilot study analysis.
|
| 92 |
high contrast volume
(1 time)
|
Complementary Therapies
(1 time)
|
CI-AKI (1 time)
CKD (1 time)
MCV (1 time)
|
2015 Short-term rosuvastatin treatment for the prevention of contrast-induced acute kidney injury in patients receiving moderate or high volumes of contrast media: a sub-analysis of the TRACK-D study.
|
| 93 |
high-carbohydrate vegan
(1 time)
|
Dietetics
(1 time)
|
DBS (1 time)
HFPM (1 time)
|
2020 Postprandial Dried Blood Spot-Based Nutritional Metabolomic Analysis Discriminates a High-Fat, High-Protein Meat-Based Diet from a High Carbohydrate Vegan Diet: A Randomized Controlled Crossover Trial.
|
| 94 |
High-context-variability
(1 time)
|
Psychology
(1 time)
|
LCV (1 time)
|
2007 The effect of context variability on source memory.
|
| 95 |
high-cut viscosity of whole blood
(1 time)
|
Complementary Therapies
(1 time)
|
ACI (1 time)
ADLs (1 time)
ADRs (1 time)
|
2020 Clinical Efficacy of Tonic Traditional Chinese Medicine Injection on Acute Cerebral Infarction: A Bayesian Network Meta-Analysis.
|
| 96 |
high-cyanide cultivar
(1 time)
|
Physiology
(1 time)
|
---
|
2002 Linamarase expression in cassava cultivars with roots of low- and high-cyanide content.
|
| 97 |
high-order cylindrical vector
(1 time)
|
Biophysics
(1 time)
|
ACV (1 time)
VHPs (1 time)
|
2021 Practical generation of arbitrary high-order cylindrical vector beams by cascading vortex half-wave plates.
|
| 98 |
HIV mono- and co-infected and hepatitis
(1 time)
|
Endocrinology
(1 time)
|
IDUs (1 time)
|
2015 Serum adiponectin in HIV-1 and hepatitis C virus mono- and co-infected Kenyan injection drug users.
|
| 99 |
holdout cross-validation
(1 time)
|
Environmental Health
(1 time)
|
LUR (1 time)
PNC (1 time)
UFP (1 time)
|
2021 High-Spatial-Resolution Estimates of Ultrafine Particle Concentrations across the Continental United States.
|
| 100 |
hollow cylinder volume
(1 time)
|
Ecological and Environmental Phenomena
(1 time)
|
De (1 time)
HA (1 time)
HR (1 time)
|
2017 Internode morphometrics and allometry of Tonkin Cane Pseudosasa amabilis.
|
A Search Service for Abbreviation / Long Form